Editor's Choice
RCT | Tamponade dressing does not reduce bleeding or pain compared to no dressing after hemorrhoidectomy.
10 Nov, 2022 | 14:06h | UTC
Commentary on Twitter
What's the role of tamponade dressing after #haemorrhoidectomy?
RCT 🇩🇪 725 patients
Tamponade dressing assoc w:
🔼pain
🟰 bleeding ratesWhy use it?#some4surgery #colorectalsurgery@Mcfark @LauraLorenzonMD @paulo_sutt https://t.co/J4bA3uSowT pic.twitter.com/Cda7ibx2rd
— BJS Open (@BjsOpen) June 2, 2022
Guideline | Intravenous maintenance fluid therapy in acute and critically ill children.
9 Nov, 2022 | 12:32h | UTC
Commentary on Twitter
The @ESPNIC_Society guidelines for IV maintenance fluid therapy in acute & critically ill children, SR/MA:
➡️indications for use
💧isotonic fluids
💧balanced solutions
💧composition: Ca, Mg, K, glucose, micronutrients
💧optimal amount#PedsICU #FOAMcc
🗞️https://t.co/ZZwHX1IaUh pic.twitter.com/KGr4e2dFg4— Intensive Care Medicine (@yourICM) October 26, 2022
AHA Scientific Statement | Arrhythmias in repaired Tetralogy of Fallot.
9 Nov, 2022 | 12:33h | UTCSummary: Arrhythmias in Repaired Tetralogy of Fallot – American Heart Association
Top Things to Know: Arrhythmias in Repaired Tetralogy of Fallot – American Heart Association
Commentary: Challenges in Managing Arrhythmias in Adult Tetralogy of Fallot – American Heart Association
RCT | Using an algorithm to stratify the risk of patients with acute heart failure may improve outcomes.
9 Nov, 2022 | 12:30h | UTCTrial of an Intervention to Improve Acute Heart Failure Outcomes – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events – TCTMD
Commentary on Twitter
The use of a validated tool for risk assessment, combined with rapid follow-up, led to a lower risk of death or hospitalization for cardiovascular causes at 30 days among patients with acute heart failure. #AHA22 https://t.co/0cbvcHl3US pic.twitter.com/kpWbRGpOJX
— NEJM (@NEJM) November 5, 2022
RCT | In infants undergoing heart surgery, prophylactic methylprednisolone did not significantly improve outcomes.
9 Nov, 2022 | 12:31h | UTCMethylprednisolone for Heart Surgery in Infants — A Randomized, Controlled Trial – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Steroids during surgery may not be helpful for infants having heart bypass – American Heart Association
Commentary on Twitter
In this randomized, controlled trial involving infants undergoing surgery with cardiopulmonary bypass, prophylactic use of methylprednisolone did not significantly reduce the likelihood of a worse outcome. #AHA22 https://t.co/jaza6JCAuk pic.twitter.com/lLrxci7SaE
— NEJM (@NEJM) November 6, 2022
Study Commentary | Radial artery beats both right internal thoracic artery and vein grafting at 15 years.
9 Nov, 2022 | 12:28h | UTC(Not published yet, presented at the American Heart Association Scientific Sessions, November 6, 2022)
RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years – TCTMD
See also:
Related:
Meta-Analysis: Radial-Artery vs Saphenous-Vein Grafts in CABG
M-A | DOACs increase the risk of arterial thrombosis vs. Vitamin-K antagonists in antiphospholipid syndrome.
9 Nov, 2022 | 12:28h | UTCDirect Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome: Meta-analysis of Randomized Controlled Trials – Journal of the American College of Cardiology (link to abstract – $ for full-text)
RCT | Effect of text messaging parents of school-aged children on outdoor time to control myopia.
9 Nov, 2022 | 12:26h | UTC
Commentary on Twitter
Using text message reminders to parents offer improved control of #myopia in schoolchildren and should be considered for use with large populations and over large geographic areas. https://t.co/6Dpue8j3Om #Research pic.twitter.com/IMpyGZUQyV
— JAMA Pediatrics (@JAMAPediatrics) September 26, 2022
Canadian guideline for the prevention and management of cardiovascular disease in primary care.
8 Nov, 2022 | 12:37h | UTCNews Release: New one-stop guideline for cardiovascular health in Canada – Canadian Medical Association Journal
NICE Guideline | Obesity: identification, assessment and management.
8 Nov, 2022 | 12:35h | UTCRelated:
ASMBS Guidelines | Indications for metabolic and bariatric surgery.
AGA clinical practice guideline on pharmacological interventions for adults with obesity.
Guideline | Preventing obesity in midlife women.
Follow-up of the ISCHEMIA trial | Similar survival after invasive vs. conservative management of stable coronary disease.
8 Nov, 2022 | 12:32h | UTCSurvival After Invasive or Conservative Management of Stable Coronary Disease – Circulation (free for a limited period)
Original Articles:
ISCHEMIA Trial: Initial Invasive vs. Conservative Strategy for Stable Coronary Disease
ISCHEMIA Trial: Management of Coronary Disease in Patients with Advanced Kidney Disease
See also:
Commentary on Twitter
#OriginalResearch simpub #AHA2022 #CIRCAHA22: From the #ISCHEMIA-EXTEND study – No difference in all-cause mortality between initial invasive vs conservative strategy but ⬇️ risk of CV mortality and ⬆️ risk of non-CV mortality w/ initial invasive strat… https://t.co/XwFS1KO02z pic.twitter.com/SG2z4D3lzY
— Circulation (@CircAHA) November 6, 2022
RCT | In patients with paroxysmal, untreated AF, cryoballoon ablation reduced recurrence compared to drug therapy.
8 Nov, 2022 | 12:29h | UTCProgression of Atrial Fibrillation after Cryoablation or Drug Therapy – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Initial treatment of paroxysmal atrial fibrillation with cryoballoon ablation was associated with a lower incidence of persistent atrial tachyarrhythmias over 3 years than rhythm-control medications. #AHA22 https://t.co/ZjLkt9L2xr pic.twitter.com/tzRiDPBSdx
— NEJM (@NEJM) November 7, 2022
RCT | Surgery reduced major adverse limb events vs. endovascular therapy in patients with chronic limb-threatening ischemia.
8 Nov, 2022 | 12:34h | UTCSurgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Bypass surgery favorable for initial treatment of chronic limb-threatening ischemia – National Institutes of Health
Commentary on Twitter
https://twitter.com/NEJM/status/1589621195632439296
Phase 2 RCT | Small interfering RNA to reduce Lipoprotein(a) in cardiovascular disease.
8 Nov, 2022 | 12:30h | UTCSmall Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Lipoprotein(a) is similar to LDL cholesterol but contains apolipoprotein(a). A trial tested the effects of an oligonucleotide drug targeting apo(a) mRNA on lipoprotein(a) concentrations in patients with CVD. #AHA22 https://t.co/eLgnrnTm5D pic.twitter.com/QmNUcxeJwX
— NEJM (@NEJM) November 6, 2022
RCT | New defibrillation strategies increased the rates of survival to hospital discharge in patients with refractory ventricular fibrillation.
8 Nov, 2022 | 12:27h | UTCDefibrillation Strategies for Refractory Ventricular Fibrillation – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: “Double shock” from two defibrillators could save more lives – Heart & Stroke
Commentary on Twitter
In a trial involving patients with refractory ventricular fibrillation, double sequential external defibrillation or vector-change defibrillation improved survival as compared with standard defibrillation. #AHA22 https://t.co/2l2t9iGnwq pic.twitter.com/SzVU93OsrX
— NEJM (@NEJM) November 6, 2022
RCT | Rapid up-titration of guideline-directed medical therapies for acute heart failure reduced readmissions and deaths.
8 Nov, 2022 | 12:24h | UTCSafety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial – The Lancet (free registration required)
News Release: Maximizing heart failure meds within 2 weeks reduced risk of hospital readmission, death – American Heart Association
Commentary: STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends – TCTMD
RCT | After an out-of-hospital cardiac arrest, fever prevention for 36 vs. 72 hours resulted in similar outcomes.
8 Nov, 2022 | 12:23h | UTCDuration of Device-Based Fever Prevention after Cardiac Arrest – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
In this trial involving patients after out-of-hospital cardiac arrest, fever prevention for 36 or 72 hours did not result in different percentages of patients dying or having severe disability or coma. #AHA22 https://t.co/Cx6x4RfqCE pic.twitter.com/vGSb0iVISN
— NEJM (@NEJM) November 6, 2022
CDC Clinical Practice Guideline for prescribing opioids for pain.
7 Nov, 2022 | 13:00h | UTCCommentaries:
CDC issues new opioid prescribing guidance, giving doctors more leeway to treat pain – NPR
NICE Guideline | Self-harm: assessment, management and preventing recurrence.
7 Nov, 2022 | 12:58h | UTC
RCT | In patients with CKD (eGFR 20-45 mL/min per 1.73 m2), Empagliflozin reduced the risk of progression of kidney disease.
7 Nov, 2022 | 12:56h | UTCEmpagliflozin in Patients with Chronic Kidney Disease – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: EMPA-KIDNEY supports SGLT2 inhibition for chronic kidney disease – medwire News
Video Summary: EMPA-KIDNEY results: Empagliflozin reduces kidney disease progression and cardiovascular deaths
Commentary on Twitter
In this trial involving patients with chronic kidney disease, empagliflozin resulted in a lower risk of disease progression or death from cardiovascular causes than placebo. #KidneyWk https://t.co/HFgzPgrRFx pic.twitter.com/EPU6Rl14F1
— NEJM (@NEJM) November 4, 2022
RCT | Triglyceride lowering with Pemafibrate fails to reduce CVD risk in patients with Type 2 DM and hypertriglyceridemia.
7 Nov, 2022 | 12:54h | UTCTriglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk – New England Journal of Medicine (link to abstract – $ for full-text)
News Releases:
Commentaries:
Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT – TCTMD
Commentary on Twitter
In a randomized trial, the incidence of cardiovascular events was not lower in patients with diabetes, HTG, and low HDL cholesterol levels who received pemafibrate, although TG, VLDL cholesterol, remnant cholesterol, and Apo C-III levels decreased. #AHA22 https://t.co/bNtIAwWTX0 pic.twitter.com/yWaTWarlsv
— NEJM (@NEJM) November 5, 2022
RCT | Early amino acids in extremely preterm infants did improve neurodisability at 2 Years.
7 Nov, 2022 | 12:52h | UTCEarly Amino Acids in Extremely Preterm Infants and Neurodisability at 2 Years – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Extra Parenteral Amino Acids No Benefit for Extremely Preterm Infants – HealthDay
Commentary on Twitter
ProVIDE trial @NEJM: In ELBW infants, extra parenteral amino acids at a dose of 1 g/day for 5 days after birth did not improve survival free from neurodisability at 2 yrs.
Higher rates of mod-sev disability noted in intervention group.https://t.co/8hT3Ol3qOi#EBNEOalerts #neoEBM pic.twitter.com/2Z9qgkQF54— Evidence-Based Neo (@EBNEO) November 5, 2022
RCT | Chlortalidone and Hydrochlorothiazide resulted in similar reductions of CVD in older patients with hypertension.
7 Nov, 2022 | 12:50h | UTCNews Release (not published yet): No difference in heart outcomes found in use of two diuretics to treat blood pressure – American Heart Association
Commentaries:
In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE – TCTMD
Diuretic Comparison Project – DCP – American College of Cardiology
RCT | Intravenous iron did not significantly reduce hospital admissions in patients with heart failure and iron deficiency.
7 Nov, 2022 | 12:48h | UTCCommentaries:
IRONMAN Misses but Lends Support to IV Iron Repletion in HF – TCTMD
Cohort Study | Preoperative hemodialysis timing and postoperative mortality in patients with end-stage kidney disease.
7 Nov, 2022 | 12:46h | UTCAssociation Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease – JAMA (free for a limited period)
Editorial: Optimal Timing of Hemodialysis Before Surgery – JAMA (free for a limited period)
Commentary from the author on Twitter (thread – click for more)
1/
In @JAMA_current, we asked: Is the timing of hemodialysis before surgery associated with postoperative mortality?The answer: YES
Here’s what we found:https://t.co/ZQl0SHZpAn
— Vikram Fielding-Singh, MD, JD (@vikramfs) November 3, 2022


